234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 11,200.00
−1.67%Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- KRW 376
- EPS estimate
- —
- Revenue actual
- KRW 56.7B
- Revenue estimate
- KRW 66.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026